Ultrasound-guided bilateral costoclavicular brachial plexus blocks for single-stage bilateral upper limb surgeries: Abstain or indulge
Madam, The primary purpose of writing this letter is to draw the readers' attention in bilateral brachial plexus block (BPB). Ever since bilateral BPB is documented in literature, the prominent concerns were local anesthetic (LA) dose/volume, bilateral phrenic nerve palsy and pneumothorax. Bilateral supraclavicular BPB clearly increases the incidence of abovementioned issues. [1] In order to overcome these complications, we are hereby submitting a case report of bilateral BPB at costoclavicular space (CCS) for bilateral upper limb surgeries.
A 38-year-old male, weighing 58 kg with a height of 168 cm, was admitted with bilateral Galeazzi fractures following alleged history of road traffic accident. He had no other associated injuries and was an American Society of Anesthesiologists physical status I patient with unremarkable blood investigations and chest X-ray findings. After obtaining informed and written consent, standard monitors (three lead ECG, oxygen saturation probe, non-invasive blood pressure cuff) were attached in the preoperative holding area. Oxygen mask was attached with 4 L/min oxygen flow. One 20G intravenous cannula was secured in the left ankle vein. Intravenous midazolam (1 mg) and Fentanyl (100 μg) were administered for anxiolysis, analgesia and sedation. Under all aseptic precautions, ultrasound-guided right-sided BPB was performed using Linear probe (8-13 MHz, Sonosite) at CCS and 15 ml of premixed LA (10 ml of 2% lignocaine with adrenaline and 20 ml of 0.5% bupivacaine) was administered.
Intraoperatively, iv paracetamol 1 gm, ketorolac 30 mg and 8 mg dexamethasone were given as part of our multimodal analgesia protocol. Open reduction and internal fixation was done over one hour. After completion of surgery, right hemi-diaphragmatic excursion was assessed with curvilinear probe (2-5 MHz) and phrenic nerve involvement was ruled out. Then, ultrasound-guided left-sided BPB was performed at CCS with 15 ml of same LA mixture. Total duration of surgery was three hours. Post procedure, we kept him under observation for 24 hours, and sonographic assessment of diaphragmatic movements was done in every four hours. No complication such as LA toxicity, phrenic nerve paralysis or pneumothorax was observed. He recovered well and was discharged after five days.
The reason for choosing CCS is that, at this location, the nerves are densely packed, which can reduce LA volume/dose, less chance of phrenic nerve palsy and pneumothorax. Having a gap inbetween the blocks reduces potential LA toxicity as the peak systemic absorption rate for each block do not coincide. The incidence of phrenic nerve palsy in costoclavicular approach is not well documented in literature due to lack of data on this relatively new approach to BPB. In a comparative study with para-coracoid approach, the authors observed hemi-diaphragmatic paralysis in 8.9% cases (4 out of 45 patients) with 35 ml of LA mixture. [2] We used only 15 ml of LA mixture on each side without any untoward effects. A study on larger population is required to find out the incidence of phrenic nerve involvement with costoclavicular approach. To conclude, ultrasound-guided single-shot costoclavicular block with low volume of LA can provide reliable and safe anesthesia for single-stage bilateral upper-limb surgeries.
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Malignant hyperthermia: An Indian perspective
Madam, Malignant hyperthermia (MH) [1] is a life-threatening disorder triggered by various anesthetic drugs. In the year 2008, the first case [2] was reported from India, at a time when it was thought to be non-existent in our population. Unlike in developed countries, there is no national registry in India for MH; hence, case reports are the only way to know its incidence and challenges in recognising/treating it.
We recently encountered MH in an 8-year-old female child, scheduled for forearm surgery. Anesthesia was induced using propofol and morphine, and maintained with O 2 , N 2 O and isoflurane, with patient breathing spontaneously on Magill circuit via laryngeal mask airway. After 90 min of uneventful anesthesia course, sudden tachypnea with hypercapnia was noted (EtCO 2 45 mmHg, RR 30/min). Within next couple of minutes tachycardia (150/min), hypertension (150/110 mmHg) and hypoxia (SpO 2 88%) occurred. Patient was also febrile to touch, which was confirmed by monitoring (38.4°C), along with muscle rigidity. Diagnosis of MH was considered, inhalation agent discontinued, Bain's circuit attached, ventilation assisted with 100% O 2 and midazolam given. Surgeons were requested to expedite the surgery. Drapes over lower body were soaked with saline. Surgery finished within next 15 min, by when EtCO 2 increased to 75 mmHg, HR to 170/min, BP to 180/110 mmHg and temperature to 39.8°C. The arterial blood gas (ABG) analysis showed acute respiratory and metabolic acidosis (pH 6.99, pCO 2 49.6 mmHg, HCO 3 -12.2 mmol/L, base-deficit 18.0 mmol/L). Upon completion of surgery whole body sponging with tepid water was initiated, trachea intubated, and controlled ventilation instituted. With continued supportive measures, EtCO 2 dropped to 60 mmHg, HR 150/min and BP 150/90 mmHg over next 30 min. ABG showed metabolic acidosis, hyperkalemia (5.9 mmol/l), raised serum urea (61 mg/dl) and normal serum creatinine (0.7 mg/dl). Aggressive cooling was continued till axillary temperature dropped to 37.8°C in the next hour. Patient's trachea was extubated after 8 hours of ventilation, following which recovery was uneventful. Repeated investigations revealed normal serum K + (4.5 mmol/L), urea (31 mg/dL) and creatinine (0.3 mg/dL), with raised creatinine kinase NAC (>2000 IU/L), creatinine kinase MB (440 IU/L) and SGOT/PT (295/601 IU/L). The patient was observed for another 36 hours and then shifted to ward for further care.
MH may have a delayed onset, occurring in 2 nd or 3 rd hour of anesthesia, as witnessed by us also. The clinical suspicion is aroused by a constellation of seemingly common events including tachycardia, tachypnea, rise in EtCO 2 , unexplained desaturation, hyperthermia and combined respiratory and metabolic acidosis, as in our case. Since the gold standard for diagnosis i.e., caffeine-halothane muscle contracture testing, [1] has limited availability it is most often based on clinical criteria. The clinical grading scale of Larach et al. [3] scores each of the clinical indicators and then retrospectively calculates probability of the event being MH. Our patient had a score of 68 that correlates with a likelihood of almost certain event.
We noted a negative end tidal CO 2 to arterial CO 2 gradient (pCO 2 49.6 mmHg with EtCO 2 of 75 mmHg). This reversal of gradient had been previously known to occur with MH. [4] Various explanations offered included increased cardiac output, increased CO 2 production. The EtCO 2 in such cases correlates with the venous CO 2 .
Treatment of MH includes discontinuation of triggering agents, ventilating with 100% O 2 and increased minute ventilation, use of dantrolene, active cooling till the core temperature reaches 38°C, correction of acidosis and hyperkalemia, treatment of
